Structural and Functional Evolution of the Vasopressin/Oxytocin Superfamily

Total Page:16

File Type:pdf, Size:1020Kb

Structural and Functional Evolution of the Vasopressin/Oxytocin Superfamily The Journal of Neuroscience, September 1995, 15(g): 5989-5998 Structural and Functional Evolution of the Vasopressin/Oxytocin Superfamily: Vasopressin-Related Conopressin Is the Only Member Present in Lymnaea, and Is Involved in the Control of Sexual Behavior R. E. Van Kesteren,’ A. B. Smit,’ R. P. J. De Lange,’ K. S. Kits,’ F. A. Van Golen,’ R. C. Van Der Schors,’ N. D. De With,’ J. F. Burke,* and W. P. M. Geraertsl ‘Graduate School Neurosciences Amsterdam, Institute of Neurosciences, Faculty of Biology, Department of Experimental Zoology, Vrije Universiteit, Amsterdam, The Netherlands and *Sussex Centre for Neuroscience, School of Biological Sciences, University of Sussex, Brighton, United Kingdom It has been suggested that the gene duplication that led to Vasopressin and oxytocin are nonapeptides that are present in the formation of the vasopressin/oxytocin two-gene family all placental mammals. Although similar in structure, they serve occurred early during vertebrate evolution. However, the different functions (Ramsay, 1983). Vasopressin has anti-diuretic existence of both vasopressin- and oxytocin-related pep- activities and is involved in hydromineral regulation, whereas tides in invertebrates suggests that this duplication may oxytocin has uterotonic and milk-ejection activities and regulates have occurred much earlier, although there is no evidence aspects of reproductive behavior. Peptides related to both vaso- for the co-occurrence of vasopressin- and oxytocin-related pressin and oxytocin are present in all vertebrate classes, except peptides in the same invertebrate species. We report here the cyclostomes, which have only the vasopressin-related pep- that in Lymnaea only the vasopressin-related peptide Lys- tide vasotocin (reviewed by Acher, 1993). Peptides of the va- conopressin, but not an oxytocin-related peptide, is pres- sopressin family have a basic amino acid residue at position 8 ent. Moreover, it is very likely that an oxytocin-like cDNA in common, whereas oxytocin and related peptides have a neu- or gene is absent. The conopressin gene is expressed in tral amino acid residue at this position. The chemical nature of neurons that control male sexual behavior, and its gene this amino acid residue is thought to be of critical importance products are present in the penis nerve and the vas defer- in the interactions of the peptides with their respective receptors. ens. Conopressin induces muscular contractions of the The structure of the protein precursors of the vasopressin/ vas deferens and inhibits central neurons that control fe- oxytocin superfamily are very similar, with a signal peptide do- male reproductive behavior. Thus, although structurally re- main followed by the nonapeptide, neurophysin, and copeptin lated to vasopressin, conopressin has functional and be- domains (reviewed by Acher, 1993), although the copeptin do- havioral characteristics typical for oxytocin. Physiological main is lacking in the oxytocin and mesotocin precursors. The and receptor binding data suggest that conopressin and precursor proteins are encoded by different genes that have an [Ile*]-conopressin, a synthetic oxytocin-like analog of cono- identical exon-intron organization in mammals (Schmale et al., pressin, are functionally equivalent in Lymnaea, and that 1983; Ivell and Richter, 1984; Ruppert et al., 1984; Sausville et the chemical nature of the amino acid residue at position al., 1985; Hara et al., 1990), bony fish (Morley et al., I990), and 8 does not result in a functional difference. Therefore, we cyclostomes (Heierhorst et al., 1992). Together with the phylo- suggest that invertebrates contain only a single member of genetic distribution of the peptides, these data suggest that the the vasopressin/oxytocin gene family and that the amino superfamily evolved from an ancestral gene by the mechanism acid change that distinguishes vasopressin from oxytocin of gene duplication. Because lampreys and hagfish have only vasotocin (Lane et al., 1988; Heierhorst et al., 1992), it has been is functionally neutral in invertebrates. hypothesized that the vasotocin gene is the present-day repre- [Key words: conopressin, vasopressin/oxytocin gene sentative of the ancestral gene, and that the gene duplication family, evolution, male sexual behavior, peptide sequenc- occurred between the radiation of cyclostomes and cartilaginous ing, gene cloning, receptor interaction, Lymnaea stagnalis] fish, about 450 million years ago (Acher, 1980). Vasopressin-related peptides are not restricted to the verte- brates, but have been identified in several invertebrate phyla as Recetved Oct. 3, 1994; revised Apr. 20, 1995; accepted Apr. 24, 1995. well, including insects (Proux et al., 1987), molluscs (Cruz et This work was supported by the Foundation for Life Sciences (SLW: Grant SOS-26.203), which is subsidized by the Netherlands Organization for Scien- al., 1987; McMaster et al., 1992) and annelids (Salzet et al., tific Research (NWO). Support was also received from the EC (BIO2CT- 1993). Oxytocin-related peptides have similarly been found in CT930169). We thank Dr. P. Van Veelen for the mass determination, Dr. G. Reich for performing the anti-oxytocin RIA, Mrs. E. R. Van Kesteren and Mr. molluscs (Reich, 1992) and annelids (Oumi et al., 1994). The J. C. Lodder for technical assistance, and Mrs. T. Laan for secretarial assistance. presence of both vasopressin- and oxytocin-related peptides in Correspondence should be addressed to Dr. R. E. Van Kesteren, Department invertebrates leads to an alternative hypothesis stating that du- of Zoology, Faculty of Biology, Vrije Universiteit, De Boelelaan 1087, 1081 HV Amsterdam. plication of the ancestral gene occurred prior to the divergence Copyright 0 1995 Society for Neuroscience 0270.6474/95/155989-10$05.00/O of vertebrates and invertebrates, over 600 million years ago (Van 5990 Van Kesteren et al. - Conopressin Controls Sexual Behavior in Lymnaea Kesteren et al., 1992). However, this hypothesis has not been Li et al. (1989). In short, 1% of each fraction was dot blotted on nitro- verified by experimental data showing co-occurrence of vaso- cellulose paper, heat fixed at 106°C for 1.5 min, and then stained with antisera W 1E and 121. Corresponding immunoreactive fractions were pressin- and oxytocin-related peptides in a single invertebrate pooled and applied to a Nucleosil 120 C-l 8 column (3 urn, 4.6 X 150 species, or by demonstrating functional divergence of the two mm) equilibrated with solvent A. Elution was achieved by a linear types of peptide in invertebrates. Thus, species variation instead gradient- of 20-35% solvent B in 60 min. Fractions were Ivoohilized.d I of gene duplication may explain the appearance of either vaso- redissolved in bidistilled water, and screened in the DIA. The immu- noreactive fraction was applied to the same C-18 column equilibrated pressin- or oxytocin-related peptides in invertebrates. with 25 mM NH,Ac for the CNS material. Elution was achieved by a In this article, we attempt to distinguish between these pos- linear gradient of IO-40% of 25 mM NH,Ac in 60% acetonitrile in 60 sibilities by studying vasopressin- and oxytocin-related peptides min. The vas deferens and penis complex material was applied to the in the mollusc Lymnuea stugnalis. Previous cDNA cloning stud- same column equilibrated with 0.05% HCl, and elution was achieved ies (Van Kesteren et al., 1992) have identified a vasopressin-like by applying 0.05% HCl/60% acetonitrile in a linear gradient of O-5% in 5 min. and 5-35% in 60 min. FmCtiOnS were lvoohilized. redissolved precursor, pro-Lys-conopressin, in Lymnaea. To demonstrate that in bidistilled water, and screened using the DIA: L conopressin has the typical tertiary structure of vasopressin-re- Sequencing, co-elution, and muss determination. The immunoreac- lated peptides and is transported to peripheral target tissues, we tive fraction of the final HPLC step was subjected to automated Edman have now identified Lys-conopressin from both the CNS and the degradation using a model 473A pulse liquid protein sequencer (Ap- male copulatory organs. At the same time, we show evidence plied Biosystems). To verify the sequence and complete the structural characterization, synthetic Lys-conopressin was used in co-elution ex- for the absence of an oxytocin-related peptide or cDNA. More- periments employing the same HPLC system, solvents, and gradients over, genomic analysis strongly suggests that the conopressin as in the first and the third rpHPLC step described above. In addition, gene is a single copy gene in Lymnuea, and that related genes the purification procedure was repeated as described above, and the are absent. Although structurally related to vasopressin, cono- immunoreactive fraction of the final HPLC step was subjected to mass pressin has functions in the control of sexual behavior that in spectrometry using a Bio-ion 20/30 plasma desorption mass spectro- meter (Applied Biosystems). mammals usually are associated with oxytocin. The implications Anti-oxytocin radioimmunoussuy. CNS of 200 snails were homoge- of these findings for theories of the molecular and functional nized, prepurified, and subjected to HPGPC as described above. All evolution of the vasopressin/oxytocin superfamily are discussed. fractions were lyophilized, redissolved in bidistilled water, and tested in an anti-oxytocin radioimmunoassay as described (Reich, 1992). Materials and Methods Polymerase chain reaction (PCR) umplijicution of putative oxytocin encoding cDNAs. Two degenerate oligonucleotides, OTI and OT2, were Animals, peptides, and antibodies. Adult specimens of L. stugnalis (shell height 28-34 mm), bred in the laboratory under standard condi- synthesized, based on the putative oxytocin-like sequences Cys-(Phe/ tions, were used. Synthetic Lys-conopressin G was obtained from Bach- Tyr)-(Phe/Ile)-Arg-Asn-Cys-Pro-(Leu/Ile/Val)-Gly and the following em Feinchemikalien AG (Budendorf, Switzerland). [Ilex]-conopressin amidation and processing sequence Gly-Lys-Arg [OTl : 5’.GGAAGC- (Cys-Phe-Be-Arg-Asn-Cys-Pro-Be-Gly-amide) was synthesized using a TTG(TC)T(AT)(TC)(AT)T(ATC)(AC)G(GATC)AA(TC)TG(TC)CC- peptide synthesizer from Applied Biosystems (Foster City, CA).
Recommended publications
  • DDAVP Nasal Spray Is Provided As an Aqueous Solution for Intranasal Use
    DDAVP® Nasal Spray (desmopressin acetate) Rx only DESCRIPTION DDAVP® Nasal Spray (desmopressin acetate) is a synthetic analogue of the natural pituitary hormone 8-arginine vasopressin (ADH), an antidiuretic hormone affecting renal water conservation. It is chemically defined as follows: Mol. wt. 1183.34 Empirical formula: C46H64N14O12S2•C2H4O2•3H2O 1-(3-mercaptopropionic acid)-8-D-arginine vasopressin monoacetate (salt) trihydrate. DDAVP Nasal Spray is provided as an aqueous solution for intranasal use. Each mL contains: Desmopressin acetate 0.1 mg Sodium Chloride 7.5 mg Citric acid monohydrate 1.7 mg Disodium phosphate dihydrate 3.0 mg Benzalkonium chloride solution (50%) 0.2 mg The DDAVP Nasal Spray compression pump delivers 0.1 mL (10 mcg) of DDAVP (desmopressin acetate) per spray. CLINICAL PHARMACOLOGY DDAVP contains as active substance desmopressin acetate, a synthetic analogue of the natural hormone arginine vasopressin. One mL (0.1 mg) of intranasal DDAVP has an antidiuretic activity of about 400 IU; 10 mcg of desmopressin acetate is equivalent to 40 IU. 1. The biphasic half-lives for intranasal DDAVP were 7.8 and 75.5 minutes for the fast and slow phases, compared with 2.5 and 14.5 minutes for lysine vasopressin, another form of the hormone used in this condition. As a result, intranasal DDAVP provides a prompt onset of antidiuretic action with a long duration after each administration. 1 2. The change in structure of arginine vasopressin to DDAVP has resulted in a decreased vasopressor action and decreased actions on visceral smooth muscle relative to the enhanced antidiuretic activity, so that clinically effective antidiuretic doses are usually below threshold levels for effects on vascular or visceral smooth muscle.
    [Show full text]
  • Endocrinology
    Endocrinology INTRODUCTION Endocrinology 1. Endocrinology is the study of the endocrine system secretions and their role at target cells within the body and nervous system are the major contributors to the flow of information between different cells and tissues. 2. Two systems maintain Homeostasis a. b 3. Maintain a complicated relationship 4. Hormones 1. The endocrine system uses hormones (chemical messengers/neurotransmitters) to convey information between different tissues. 2. Transport via the bloodstream to target cells within the body. It is here they bind to receptors on the cell surface. 3. Non-nutritive Endocrine System- Consists of a variety of glands working together. 1. Paracrine Effect (CHEMICAL) Endocrinology Spring 2013 Page 1 a. Autocrine Effect i. Hormones released by cells that act on the membrane receptor ii. When a hormone is released by a cell and acts on the receptors located WITHIN the same cell. Endocrine Secretions: 1. Secretions secreted Exocrine Secretion: 1. Secretion which come from a gland 2. The secretion will be released into a specific location Nervous System vs tHe Endocrine System 1. Nervous System a. Neurons b. Homeostatic control of the body achieved in conjunction with the endocrine system c. Maintain d. This system will have direct contact with the cells to be affected e. Composed of both the somatic and autonomic systems (sympathetic and parasympathetic) Endocrinology Spring 2013 Page 2 2. Endocrine System a. b. c. 3. Neuroendocrine: a. These are specialized neurons that release chemicals that travel through the vascular system and interact with target tissue. b. Hypothalamus à posterior pituitary gland History of tHe Endocrine System Bertold (1849)-FATHER OF ENDOCRINOLOGY 1.
    [Show full text]
  • Atrazine and Cell Death Symbol Synonym(S)
    Supplementary Table S1: Atrazine and Cell Death Symbol Synonym(s) Entrez Gene Name Location Family AR AIS, Andr, androgen receptor androgen receptor Nucleus ligand- dependent nuclear receptor atrazine 1,3,5-triazine-2,4-diamine Other chemical toxicant beta-estradiol (8R,9S,13S,14S,17S)-13-methyl- Other chemical - 6,7,8,9,11,12,14,15,16,17- endogenous decahydrocyclopenta[a]phenanthrene- mammalian 3,17-diol CGB (includes beta HCG5, CGB3, CGB5, CGB7, chorionic gonadotropin, beta Extracellular other others) CGB8, chorionic gonadotropin polypeptide Space CLEC11A AW457320, C-type lectin domain C-type lectin domain family 11, Extracellular growth factor family 11, member A, STEM CELL member A Space GROWTH FACTOR CYP11A1 CHOLESTEROL SIDE-CHAIN cytochrome P450, family 11, Cytoplasm enzyme CLEAVAGE ENZYME subfamily A, polypeptide 1 CYP19A1 Ar, ArKO, ARO, ARO1, Aromatase cytochrome P450, family 19, Cytoplasm enzyme subfamily A, polypeptide 1 ESR1 AA420328, Alpha estrogen receptor,(α) estrogen receptor 1 Nucleus ligand- dependent nuclear receptor estrogen C18 steroids, oestrogen Other chemical drug estrogen receptor ER, ESR, ESR1/2, esr1/esr2 Nucleus group estrone (8R,9S,13S,14S)-3-hydroxy-13-methyl- Other chemical - 7,8,9,11,12,14,15,16-octahydro-6H- endogenous cyclopenta[a]phenanthren-17-one mammalian G6PD BOS 25472, G28A, G6PD1, G6PDX, glucose-6-phosphate Cytoplasm enzyme Glucose-6-P Dehydrogenase dehydrogenase GATA4 ASD2, GATA binding protein 4, GATA binding protein 4 Nucleus transcription TACHD, TOF, VSD1 regulator GHRHR growth hormone releasing
    [Show full text]
  • Diversity of Central Oxytocinergic Projections
    Cell and Tissue Research (2019) 375:41–48 https://doi.org/10.1007/s00441-018-2960-5 REVIEW Diversity of central oxytocinergic projections Gustav F. Jirikowski1 Received: 21 September 2018 /Accepted: 6 November 2018 /Published online: 29 November 2018 # Springer-Verlag GmbH Germany, part of Springer Nature 2018 Abstract Localization and distribution of hypothalamic neurons expressing the nonapeptide oxytocin has been extensively studied. Their projections to the neurohypophyseal system release oxytocin into the systemic circulation thus controlling endocrine events associated with reproduction in males and females. Oxytocinergic neurons seem to be confined to the ventral hypothalamus in all mammals. Groups of such cells located outside the supraoptic and the paraventricular nuclei are summarized as Baccessory neurons.^ Although evolutionary probably associated with the classical magocellular nuclei, accessory oxytocin neurons seem to consist of rather heterogenous groups: Periventricular oxytocin neurons may gain contact to the third ventricle to secrete the peptide into the cerebrospinal fluid. Perivascular neurons may be involved in control of cerebral blood flow. They may also gain access to the portal circulation of the anterior pituitary lobe. Central projections of oxytocinergic neurons extend to portions of the limbic system, to the mesencephalon and to the brain stem. Such projections have been associated with control of behaviors, central stress response as well as motor and vegetative functions. Activity of the different oxytocinergic systems seems to be malleable to functional status, strongly influenced by systemic levels of steroid hormones. Keywords Hypothalamo neurohypophyseal system . Circumventricular organs . Liquor contacting neurons . Perivascular system . Limbic system Introduction been shown to occur in prostate, gonads, or skin, OTexpression in the brain seems to be confined to the hypothalamus.
    [Show full text]
  • Oxytocin-Functions: an Overview
    MOJ Anatomy & Physiology Review Article Open Access Oxytocin-functions: an overview Abstract Volume 6 Issue 4 - 2019 Oxytocin is a neuropeptide containing nine amino acids produced by paraventricular and supraoptic nuclei of hypothalamus. Oxytocin is derived from a Greek word ‘oxutokia’ Roopasree B, Jophy Joseph, Mukkadan JK meaning sudden delivery and it is well known for its role in parturition and lactation. In Department of Physiology, Little Flower Institute of Medical addition oxytocin performs a wide spectrum of functions. Oxytocin is a hormone with great Sciences and Research, India potential and it is a great facilitator of life. The purpose of this review is to cover almost all the functions of oxytocin - reproductive functions, social functions, role in human Correspondence: Mukkadan JK, Research Director, Department of Physiology, Little Flower Medical Research behaviour and other biologically significant functions.. Centre LFMRC, Angamaly, Kerala, India, Tel 91 9387518037, Fax Keywords: oxytocin, functions, neurophysin I, magnocellular neurons 0484 2452646, Email Received: July 24, 2019 | Published: August 16, 2019 Introduction (GPCR) family. It is coupled to phospholipase C through Gαq11.20,21 Once Oxytocin binds to its receptor, it gives rise to a cascade of Oxytocin is a non a-peptide hormone containing nine amino acids, reactions that finally activates the enzyme Phospholipase-C. This with one disulphide linkage between the 1st and 6th cysteine residue. enzyme produces ITP (inositol triphosphate) and DAG (1, 2-diacyl It is also called as α-Hypophamine. Half-life is found to be minutes. It glycerol) and also activates intracellular Ca++ release, which in turn is known to be the 1st polypeptide hormone that has been sequenced set off various cellular events.9 and synthesized biochemically.
    [Show full text]
  • Corticotropin-Releasing Activity of Lysine Vasopressin Evelyn Joyce Weber Iowa State University
    Iowa State University Capstones, Theses and Retrospective Theses and Dissertations Dissertations 1961 Corticotropin-releasing activity of lysine vasopressin Evelyn Joyce Weber Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/rtd Part of the Biochemistry Commons Recommended Citation Weber, Evelyn Joyce, "Corticotropin-releasing activity of lysine vasopressin " (1961). Retrospective Theses and Dissertations. 1990. https://lib.dr.iastate.edu/rtd/1990 This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. This dissertation has been 62-1374 microfilmed exactly as received WEBER, Evelyn Joyce, 1928- CORTICOTRO PIN-RE LEASING ACTIVITY OF LYSINE VASOPRESSIN. Iowa State University of Science and Technology Ph.D., 1961 Chemistry, biological University Microfilms, Inc., Ann Arbor, Michigan CORTICO TROPIN-RELEASING ACTIVITY OF LYSINE 7AS0PRESSII Evelyn Joyce Weber A Dissertation Submitted, to the Graduate Faculty in Partial Fulfillment of The Requirements for the Degree of DOCTOR OF PHILOSOPHY . kajor Subject: Biochemistry Approved: Signature was redacted for privacy. In Charge of l-.ejor V,rork Signature was redacted for privacy. Head, of kajor Department Signature was redacted for privacy. Deacf of Gradu/ue College Iowa State University Of Science and Technology Ames, loua 1961 il TABLE OF CONTENTS Page HISTORICAL . ; 1 Biological Activities of Vasopressin. ...... -3 Pressor activity 3 Antidiuretic activity 5 Oxytocic activity. £ Corticotropin releasing activity 10 Other activities of vasopressin.
    [Show full text]
  • Management and Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus
    REVIEW Management and treatment of lithium- induced nephrogenic diabetes insipidus Christopher K Finch†, Lithium carbonate is a well documented cause of nephrogenic diabetes insipidus, with as Tyson WA Brooks, many as 10 to 15% of patients taking lithium developing this condition. Clinicians have Peggy Yam & Kristi W Kelley been well aware of lithium toxicity for many years; however, the treatment of this drug- induced condition has generally been remedied by discontinuation of the medication or a †Author for correspondence Methodist University reduction in dose. For those patients unresponsive to traditional treatment measures, Hospital, Department several pharmacotherapeutic regimens have been documented as being effective for the of Pharmacy, University of management of lithium-induced diabetes insipidus including hydrochlorothiazide, Tennessee, College of Pharmacy, 1265 Union Ave., amiloride, indomethacin, desmopressin and correction of serum lithium levels. Memphis, TN 38104, USA Tel.: +1 901 516 2954 Fax: +1 901 516 8178 [email protected] Lithium carbonate is well known for its wide use associated with a mutation(s) of vasopressin in bipolar disorders due to its mood stabilizing receptors. Acquired causes are tubulointerstitial properties. It is also employed in aggression dis- disease (e.g., sickle cell disease, amyloidosis, orders, post-traumatic stress disorders, conduct obstructive uropathy), electrolyte disorders (e.g., disorders and even as adjunctive therapy in hypokalemia and hypercalcemia), pregnancy, or depression. Lithium has many well documented conditions induced by a drug (e.g., lithium, adverse effects as well as a relatively narrow ther- demeclocycline, amphotericin B and apeutic range of 0.4 to 0.8 mmol/l. Clinically vincristine) [3,4]. Lithium is the most common significant adverse effects include polyuria, mus- cause of drug-induced nephrogenic DI [5].
    [Show full text]
  • Review Article Mouse Homologues of Human Hereditary Disease
    I Med Genet 1994;31:1-19 I Review article J Med Genet: first published as 10.1136/jmg.31.1.1 on 1 January 1994. Downloaded from Mouse homologues of human hereditary disease A G Searle, J H Edwards, J G Hall Abstract involve homologous loci. In this respect our Details are given of 214 loci known to be genetic knowledge of the laboratory mouse associated with human hereditary dis- outstrips that for all other non-human mam- ease, which have been mapped on both mals. The 829 loci recently assigned to both human and mouse chromosomes. Forty human and mouse chromosomes3 has now two of these have pathological variants in risen to 900, well above comparable figures for both species; in general the mouse vari- other laboratory or farm animals. In a previous ants are similar in their effects to the publication,4 102 loci were listed which were corresponding human ones, but excep- associated with specific human disease, had tions include the Dmd/DMD and Hprt/ mouse homologues, and had been located in HPRT mutations which cause little, if both species. The number has now more than any, harm in mice. Possible reasons for doubled (table 1A). Of particular interest are phenotypic differences are discussed. In those which have pathological variants in both most pathological variants the gene pro- the mouse and humans: these are listed in table duct seems to be absent or greatly 2. Many other pathological mutations have reduced in both species. The extensive been detected and located in the mouse; about data on conserved segments between half these appear to lie in conserved chromo- human and mouse chromosomes are somal segments.
    [Show full text]
  • VASOPRESSIN and OXYTOCIN Molecular, Cellular, and Clinical Advances ADVANCES in EXPERIMENTAL MEDICINE and BIOLOGY
    VASOPRESSIN AND OXYTOCIN Molecular, Cellular, and Clinical Advances ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY Editorial Board: NATHAN BACK, State University of New York at Buffalo IRUN R. COHEN, The Weizmann Institute of Science DAVID KRITCHEVSKY, Wistar Institute ABEL LAJTHA, N. S. Kline Institutefor Psychiatric Research RODOLFO PAOLETTI, University of Milan Recent Volumes in this Series Volume 443 ADV ANCES IN LACTOFERRIN RESEARCH Edited by Genevieve Spik, Dominique Legrand, Joel Mazurier, Annick Pierce, and Jean-Paul Perraudin Volume 444 REPRODUCTIVE TOXICOLOGY: In Vitro Germ Cell Developmental Toxicology, from Science to Social and Industrial Demand Edited by Jesus del Mazo Volume 445 MA THEMA TICAL MODELING IN EXPERIMENTAL NUTRITION Edited by Andrew J. Clifford and Hans-Georg MUlier Volume 446 MOLECULAR AND CELLULAR MECHANISMS OF NEURONAL PLASTICITY: Basic and Clinical Implications Edited by Yigal H. Ehrlich Volume 447 LIPOXYGENASES AND THEIR METABOLITES: Biological Functions Edited by Santosh Nigam and Cecil R. Pace-Asciak Volume 448 COPPER TRANSPORT AND ITS DISORDERS: Molecular aIfd Cellular Aspects Edited by Arturo Leone and Julian F. B. Mercer Volume 449 VASOPRESSIN AND OXYTOCIN: Molecular, Cellular, and Clinical Advances Edited by Harts H.Zingg, Charles W. Bourque, and Daniel G. Bichet Volume 450 ADV ANCES IN MODELING AND CONTROL OF VENTILATION Edited by Richard L. Hughson, David A. Cunningham, and James Duffin Volume 451 GENE THERAPY OF CANCER Edited by Peter Walden, Uwe Trefzer, Wolfram Sterry, and Farzin Farzaneh Volume 452 MECHANISMS OF LYMPHOCYTE ACTIVATION AND IMMUNE REGULATION VII: Molecular Determinants of Microbial Immunity Edited by Sudhir Gupta, Alan Sher, and Rafi Ahmed A Continuation Order Plan is available for this series.
    [Show full text]
  • Demeclocycline in the Treatment of the Syndrome of Inappropriate Secretion of Antidiuretic Hormone
    Thorax: first published as 10.1136/thx.34.3.324 on 1 June 1979. Downloaded from Thorax, 1979, 34, 324-327 Demeclocycline in the treatment of the syndrome of inappropriate secretion of antidiuretic hormone W H PERKS, E H WALTERS,' I P TAMS, AND K PROWSE From the Department of Respiratory Physiology, City General Hospital, Stoke-on-Trent, Staffordshire, UK ABSTRACT Fourteen patients with the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) have been treated with demethylchlortetracycline (demeclocycline) 1200 mg daily. In 12 patients the underlying lesion was malignant. The serum sodium returned to normal (> 135 mmol/l) in all patients after a mean of 8-6 days (SD+5-3 days). Blood urea rose significantly from the pretreatment level of 4-2±2-3 mmol/l to 10-1±5-1 mmol/l at ten days (p<0 001). The average maximum blood urea was 13-4-6-8 mmol/l. In four patients the urea rose above 20 mmol/l, and in two of these demecyocycline was discontinued because of this rise. The azotaemia could be attributed to a combination of increased urea production and a mild specific drug-induced nephrotoxicity. Discontinuation of demeclocycline in six patients led to a fall in serum sodium, in one case precipitously, and return of the urea towards normal levels. Demeclocycline appears therefore to be an effective maintenance treatment of SIADH, and the azotaemia that occurs is reversible and probably dose dependent. The syndrome of inappropriate secretion of anti- Methods http://thorax.bmj.com/ diuretic hormone (SIADH) has become increas- ingly recognised as a treatable cause of stupor and Fourteen patients with a diagnosis of SIADH confusion in patients with a wide variety of based on the criteria of De Troyer and Demanet diseases (De Troyer and Demanet, 1976).
    [Show full text]
  • Hypernatremia: 2 Months Back When He Had Progressive Decrease in Vision (Right > Left)
    Correspondence to increased intrathoracic pressure and central radiologist regarding vascular injury when there is venous pressure, decreased venous return from the refractory hypotension so that necessary steps can be brain and increased ICP[4] taken to identify and treat iatrogenic complications that • Patients with aneurysmal SAH have disturbed might compound the pre‑existing morbidity. autoregulation of cerebral blood flow. Hence, intraoperative hypotension of any cause has an REFERENCES adverse effect on the outcome of SAH[5,6] • Patients with poor grade SAH (Fischer III/IV) and 1. Young WL, Pile-Spellman J. Anesthetic considerations for interventional Neuroradiolgy (Review). Anesthesiology angiographic evidence of vasospasm which our 1994;80:427-56. patient had, are at risk for cerebral hypoperfusion 2. Varma MK, Price K, Jayakrishnan V, Manickam B, Kessell G. because of impaired cerebral autoregulation and Anaesthetic considerations for interventional neuroradiology. thus intraoperative hypotension and cerebral Br J Anaesth 2007;99:75-85. [6,7] 3. Kent KC, Moscucci M, Mansour KA, Dimattia S, Gallagher S, hypoperfusion compounds the poor outcome Kuntz R, et al. Retroperitoneal hematoma after cardiac • Blood loss leading to severe anaemia (Hb 3.8 g%) catheterization: Prevalence, risk factors, and optimal during the procedure might have lead to decreased management. J Vasc Surg 1994;20:905-10. oxygen‑carrying capacity of blood and further 4. De Laet I, Citerio G, Malbrain ML. The influence of exacerbate the hypoxic injury to brain. intraabdominal hypertension on the central nervous system: Current insights and clinical recommendations, is it all in the Thus a combination of age, poor grade SAH, diffuse head? Acta Clin Belg Suppl 2007;1:89-97.
    [Show full text]
  • Estonian Statistics on Medicines 2013 1/44
    Estonian Statistics on Medicines 2013 DDD/1000/ ATC code ATC group / INN (rout of admin.) Quantity sold Unit DDD Unit day A ALIMENTARY TRACT AND METABOLISM 146,8152 A01 STOMATOLOGICAL PREPARATIONS 0,0760 A01A STOMATOLOGICAL PREPARATIONS 0,0760 A01AB Antiinfectives and antiseptics for local oral treatment 0,0760 A01AB09 Miconazole(O) 7139,2 g 0,2 g 0,0760 A01AB12 Hexetidine(O) 1541120 ml A01AB81 Neomycin+Benzocaine(C) 23900 pieces A01AC Corticosteroids for local oral treatment A01AC81 Dexamethasone+Thymol(dental) 2639 ml A01AD Other agents for local oral treatment A01AD80 Lidocaine+Cetylpyridinium chloride(gingival) 179340 g A01AD81 Lidocaine+Cetrimide(O) 23565 g A01AD82 Choline salicylate(O) 824240 pieces A01AD83 Lidocaine+Chamomille extract(O) 317140 g A01AD86 Lidocaine+Eugenol(gingival) 1128 g A02 DRUGS FOR ACID RELATED DISORDERS 35,6598 A02A ANTACIDS 0,9596 Combinations and complexes of aluminium, calcium and A02AD 0,9596 magnesium compounds A02AD81 Aluminium hydroxide+Magnesium hydroxide(O) 591680 pieces 10 pieces 0,1261 A02AD81 Aluminium hydroxide+Magnesium hydroxide(O) 1998558 ml 50 ml 0,0852 A02AD82 Aluminium aminoacetate+Magnesium oxide(O) 463540 pieces 10 pieces 0,0988 A02AD83 Calcium carbonate+Magnesium carbonate(O) 3049560 pieces 10 pieces 0,6497 A02AF Antacids with antiflatulents Aluminium hydroxide+Magnesium A02AF80 1000790 ml hydroxide+Simeticone(O) DRUGS FOR PEPTIC ULCER AND GASTRO- A02B 34,7001 OESOPHAGEAL REFLUX DISEASE (GORD) A02BA H2-receptor antagonists 3,5364 A02BA02 Ranitidine(O) 494352,3 g 0,3 g 3,5106 A02BA02 Ranitidine(P)
    [Show full text]